MedPath

To study the effect of kantakari avaleha in kasa with investigation of total leukocyte count

Phase 2
Conditions
Health Condition 1: R05- Cough
Registration Number
CTRI/2024/08/072072
Lead Sponsor
Dr Abhishek Dayanand Kamane
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with acute onset of Kasa of less than two Weeks duration was included.

Patients have fulfilling criteria for diagnosis of

Cough, Shirshool, Parshvashol , Uroshool, Daha, Kantha Kandu , Peenasa

Exclusion Criteria

Patient of Kshataj and Kshayaj Kasa.

Pregnant and lactating women

Known case of Chronic obstructive Pulmonary disease, pneumonia, Bronchiectasis, lung abscess, pulmonary edema, HIV, HBsAg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To decrease the signs and symptoms of Kasa <br/ ><br>Timepoint: 21 days study with follow up on 7th, 14th,and 21st day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To study the adverse effect of Ayurvedic <br/ ><br>formulation, if any.Timepoint: 21 days study with follow up on 7th,14th & 21st day
© Copyright 2025. All Rights Reserved by MedPath